How to Read an NGS Cancer Report
Variants, biomarkers, evidence tiers and the questions to take to your oncologist
Written byTeam Oncquest
DJ
Reviewer
Reviewer profile
Dr. Jasmine Kaur
Dr. Jasmine Kaur is a Consultant in R&D in the Molecular Biology and Genomics Department at Oncquest Laboratories.
10
Articles reviewedof 11 in the library
4
Topics coveredAcross published contributions
Oct 202026
Latest article updatePublished content
About
Background
Dr. Jasmine Kaur is a Consultant in R&D in the Molecular Biology and Genomics Department at Oncquest Laboratories. She holds a PhD in Biotechnology from Jamia Hamdard, New Delhi, and an MPhil, with more than seven years of post-PhD experience in molecular diagnostics. Her work includes developing, standardising and validating clinically relevant molecular assays and analysing genomic biomarkers for medical testing.
Topics covered
Review record
Reviewed Articles 10
3 articles in the selected topic.
CGP 550 Plus and CGP 270 Plus Cancer Testing
How the panels differ and how to read a comprehensive genomic profile
10 min read
Written byTeam Oncquest
Variant Allele Frequency in Cancer NGS Reports
What VAF measures, why percentages vary and what they cannot tell you alone
8 min read
Written byTeam Oncquest